skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
NONE
Issue Dt:
Application #:
17082994
Filing Dt:
10/28/2020
Publication #:
20210284713
Pub Dt:
09/16/2021
Inventors:
Kayvan Niazi, Jay Gardner Nelson, Annie Shin, Clifford Anders Olson, Shiho Tanaka
Title:
ANTI COVID-19 THERAPIES USING CD40 LIGAND FUSION PROTEIN
Assignment: 1
Reel/Frame:
054200/0956Recorded: 10/28/2020Pages: 9
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
NIAZI, KAYVAN
Exec Dt:
10/15/2020
NELSON, JAY GARDNER
Exec Dt:
09/10/2020
SHIN, ANNIE
Exec Dt:
09/21/2020
OLSON, CLIFFORD ANDERS
Exec Dt:
09/21/2020
TANAKA, SHIHO
Exec Dt:
09/09/2020
Assignee:
IMMUNITYBIO, INC.
9920 JEFFERSON BLVD.
CULVER CITY, CALIFORNIA 90232
Correspondent:
UMBERG ZIPSER, LLP
1920 MAIN STREET, SUITE 750
IRVINE, CA 92614
Assignment: 2
Reel/Frame:
057438/0014Recorded: 09/08/2021Pages: 4
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
IMMUNITYBIO, INC.
Exec Dt:
03/09/2021
Assignee:
NANTCELL, INC.
9920 JEFFERSON BLVD.
CULVER CITY, CALIFORNIA 90232
Correspondent:
UMBERG ZIPSER LLP
1920 MAIN STREET, SUITE 750
IRVINE, CA 92614

Search Results as of: 07/10/2025 01:00 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT